nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—Mycophenolic acid—psoriasis	0.417	1	CrCtD
Mycophenolate mofetil—systemic scleroderma—psoriasis	0.149	0.551	CtDrD
Mycophenolate mofetil—systemic lupus erythematosus—psoriasis	0.121	0.449	CtDrD
Mycophenolate mofetil—UGT1A7—Mycophenolic acid—psoriasis	0.0668	0.277	CbGbCtD
Mycophenolate mofetil—IMPDH2—Mycophenolic acid—psoriasis	0.0483	0.2	CbGbCtD
Mycophenolate mofetil—IMPDH1—Mycophenolic acid—psoriasis	0.0383	0.159	CbGbCtD
Mycophenolate mofetil—UGT1A6—Mycophenolic acid—psoriasis	0.0277	0.115	CbGbCtD
Mycophenolate mofetil—UGT1A9—Mycophenolic acid—psoriasis	0.00808	0.0335	CbGbCtD
Mycophenolate mofetil—UGT2B7—Mycophenolic acid—psoriasis	0.00765	0.0317	CbGbCtD
Mycophenolate mofetil—UGT1A1—Mycophenolic acid—psoriasis	0.00661	0.0274	CbGbCtD
Mycophenolate mofetil—ALB—Acitretin—psoriasis	0.00299	0.0124	CbGbCtD
Mycophenolate mofetil—CYP2C8—Tazarotene—psoriasis	0.00292	0.0121	CbGbCtD
Mycophenolate mofetil—CYP3A5—Beclomethasone—psoriasis	0.00283	0.0117	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Cyclosporine—psoriasis	0.00194	0.00803	CbGbCtD
Mycophenolate mofetil—SLCO1B3—Methotrexate—psoriasis	0.00176	0.0073	CbGbCtD
Mycophenolate mofetil—ABCC2—Cyclosporine—psoriasis	0.0017	0.00705	CbGbCtD
Mycophenolate mofetil—ABCG2—Hydrocortisone—psoriasis	0.00163	0.00675	CbGbCtD
Mycophenolate mofetil—ABCG2—Cyclosporine—psoriasis	0.00154	0.00638	CbGbCtD
Mycophenolate mofetil—CYP2C8—Cholecalciferol—psoriasis	0.00125	0.00517	CbGbCtD
Mycophenolate mofetil—ABCC2—Dexamethasone—psoriasis	0.00112	0.00465	CbGbCtD
Mycophenolate mofetil—ALB—Prednisone—psoriasis	0.00112	0.00464	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Methotrexate—psoriasis	0.00103	0.00425	CbGbCtD
Mycophenolate mofetil—ABCG2—Dexamethasone—psoriasis	0.00101	0.0042	CbGbCtD
Mycophenolate mofetil—CYP3A4—Calcitriol—psoriasis	0.000983	0.00407	CbGbCtD
Mycophenolate mofetil—CYP3A5—Hydrocortisone—psoriasis	0.000903	0.00374	CbGbCtD
Mycophenolate mofetil—ABCC2—Methotrexate—psoriasis	0.000901	0.00373	CbGbCtD
Mycophenolate mofetil—CYP2C8—Hydrocortisone—psoriasis	0.000869	0.0036	CbGbCtD
Mycophenolate mofetil—CYP3A5—Cyclosporine—psoriasis	0.000853	0.00353	CbGbCtD
Mycophenolate mofetil—CYP2C8—Cyclosporine—psoriasis	0.00082	0.0034	CbGbCtD
Mycophenolate mofetil—ABCG2—Methotrexate—psoriasis	0.000815	0.00338	CbGbCtD
Mycophenolate mofetil—CYP3A4—Methoxsalen—psoriasis	0.000764	0.00317	CbGbCtD
Mycophenolate mofetil—ABCB1—Betamethasone—psoriasis	0.000629	0.0026	CbGbCtD
Mycophenolate mofetil—ABCB1—Prednisolone—psoriasis	0.00062	0.00257	CbGbCtD
Mycophenolate mofetil—ABCB1—Hydrocortisone—psoriasis	0.000588	0.00244	CbGbCtD
Mycophenolate mofetil—ABCB1—Prednisone—psoriasis	0.000586	0.00243	CbGbCtD
Mycophenolate mofetil—CYP3A5—Dexamethasone—psoriasis	0.000562	0.00233	CbGbCtD
Mycophenolate mofetil—ALB—Methotrexate—psoriasis	0.000562	0.00233	CbGbCtD
Mycophenolate mofetil—ABCB1—Cyclosporine—psoriasis	0.000555	0.0023	CbGbCtD
Mycophenolate mofetil—CYP2C8—Dexamethasone—psoriasis	0.00054	0.00224	CbGbCtD
Mycophenolate mofetil—CYP3A4—Cholecalciferol—psoriasis	0.000506	0.0021	CbGbCtD
Mycophenolate mofetil—CYP3A4—Triamcinolone—psoriasis	0.000439	0.00182	CbGbCtD
Mycophenolate mofetil—CYP3A4—Betamethasone—psoriasis	0.000377	0.00156	CbGbCtD
Mycophenolate mofetil—CYP3A4—Prednisolone—psoriasis	0.000372	0.00154	CbGbCtD
Mycophenolate mofetil—ABCB1—Dexamethasone—psoriasis	0.000366	0.00151	CbGbCtD
Mycophenolate mofetil—CYP3A4—Hydrocortisone—psoriasis	0.000352	0.00146	CbGbCtD
Mycophenolate mofetil—CYP3A4—Prednisone—psoriasis	0.000351	0.00145	CbGbCtD
Mycophenolate mofetil—CYP3A4—Cyclosporine—psoriasis	0.000333	0.00138	CbGbCtD
Mycophenolate mofetil—ABCB1—Methotrexate—psoriasis	0.000294	0.00122	CbGbCtD
Mycophenolate mofetil—CYP3A4—Dexamethasone—psoriasis	0.000219	0.000907	CbGbCtD
Mycophenolate mofetil—IMPDH2—Levonorgestrel—Hydrocortisone—psoriasis	0.000178	1	CbGdCrCtD
Mycophenolate mofetil—CES2—Fluoropyrimidine Activity—TP53—psoriasis	6.53e-05	0.00877	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Oxidative Stress—NFKB1—psoriasis	6.37e-05	0.00856	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—NRF2 pathway—TGFA—psoriasis	6.32e-05	0.0085	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	6.21e-05	0.00834	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Biological oxidations—CYP2S1—psoriasis	6.2e-05	0.00833	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	6.16e-05	0.00827	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metapathway biotransformation—CYP2S1—psoriasis	6.11e-05	0.00821	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	6.08e-05	0.00817	CbGpPWpGaD
Mycophenolate mofetil—CES1—NRF2 pathway—TGFA—psoriasis	6.01e-05	0.00807	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	5.76e-05	0.00774	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	5.61e-05	0.00754	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	5.61e-05	0.00754	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	5.44e-05	0.00731	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.24e-05	0.00704	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Biological oxidations—CYP2S1—psoriasis	5.04e-05	0.00677	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Biological oxidations—CYP2S1—psoriasis	5.04e-05	0.00677	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	4.99e-05	0.00671	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metapathway biotransformation—CYP2S1—psoriasis	4.97e-05	0.00667	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metapathway biotransformation—CYP2S1—psoriasis	4.97e-05	0.00667	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—HIF-1-alpha transcription factor network—CP—psoriasis	4.71e-05	0.00632	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	4.7e-05	0.00632	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—NDUFA5—psoriasis	4.52e-05	0.00607	CbGpPWpGaD
Mycophenolate mofetil—ALB—HDL-mediated lipid transport—APOE—psoriasis	4.33e-05	0.00582	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	4.29e-05	0.00577	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—NDUFA5—psoriasis	4.03e-05	0.00541	CbGpPWpGaD
Mycophenolate mofetil—CES1—Fluoropyrimidine Activity—TP53—psoriasis	3.85e-05	0.00517	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—CYP2S1—psoriasis	3.84e-05	0.00516	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—NDUFA5—psoriasis	3.68e-05	0.00495	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.65e-05	0.00491	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	3.52e-05	0.00473	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—PPARA activates gene expression—CARM1—psoriasis	3.52e-05	0.00473	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—NRF2 pathway—TGFA—psoriasis	3.45e-05	0.00464	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	3.44e-05	0.00462	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—CYP2S1—psoriasis	3.42e-05	0.0046	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	3.31e-05	0.00444	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	3.26e-05	0.00438	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—CYP2S1—psoriasis	3.13e-05	0.00421	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—NDUFA5—psoriasis	3.13e-05	0.00421	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Biological oxidations—CYP2S1—psoriasis	3.06e-05	0.00411	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	3.02e-05	0.00406	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—NRF2 pathway—TGFA—psoriasis	2.8e-05	0.00377	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—NRF2 pathway—TGFA—psoriasis	2.8e-05	0.00377	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—NRF2 pathway—TGFA—psoriasis	2.74e-05	0.00368	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	2.68e-05	0.0036	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—CYP2S1—psoriasis	2.66e-05	0.00358	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Biological oxidations—CYP2S1—psoriasis	2.65e-05	0.00356	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	2.64e-05	0.00355	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	2.62e-05	0.00351	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	2.54e-05	0.00342	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—SLC-mediated transmembrane transport—CP—psoriasis	2.53e-05	0.00339	CbGpPWpGaD
Mycophenolate mofetil—ALB—Lipoprotein metabolism—APOE—psoriasis	2.49e-05	0.00334	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	2.46e-05	0.00331	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	2.41e-05	0.00324	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	2.41e-05	0.00324	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	2.37e-05	0.00319	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—NDUFA5—psoriasis	2.28e-05	0.00307	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—HIF-1-alpha transcription factor network—LEP—psoriasis	2.15e-05	0.00288	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	2.09e-05	0.0028	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	2.09e-05	0.0028	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—SERPINB8—psoriasis	2.03e-05	0.00273	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—HIF-1-alpha transcription factor network—NOS2—psoriasis	2e-05	0.00269	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—HIF-2-alpha transcription factor network—VEGFA—psoriasis	1.97e-05	0.00265	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—HLA-C—psoriasis	1.96e-05	0.00264	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—IL13—psoriasis	1.95e-05	0.00262	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—CYP2S1—psoriasis	1.94e-05	0.00261	CbGpPWpGaD
Mycophenolate mofetil—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	1.94e-05	0.0026	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—CARM1—psoriasis	1.88e-05	0.00252	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—IL17A—psoriasis	1.8e-05	0.00241	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.72e-05	0.00231	CbGpPWpGaD
Mycophenolate mofetil—ALB—Folate Metabolism—CAT—psoriasis	1.7e-05	0.00229	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—SLC-mediated transmembrane transport—CP—psoriasis	1.7e-05	0.00228	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—CARM1—psoriasis	1.67e-05	0.00225	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—IL12B—psoriasis	1.67e-05	0.00224	CbGpPWpGaD
Mycophenolate mofetil—ALB—Vitamin B12 Metabolism—CRP—psoriasis	1.66e-05	0.00223	CbGpPWpGaD
Mycophenolate mofetil—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	1.65e-05	0.00222	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—HLA-E—psoriasis	1.63e-05	0.00219	CbGpPWpGaD
Mycophenolate mofetil—ALB—Vitamin B12 Metabolism—APOE—psoriasis	1.63e-05	0.00219	CbGpPWpGaD
Mycophenolate mofetil—ALB—Folate Metabolism—IL4—psoriasis	1.57e-05	0.0021	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	1.56e-05	0.0021	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	1.56e-05	0.0021	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—CARM1—psoriasis	1.53e-05	0.00205	CbGpPWpGaD
Mycophenolate mofetil—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	1.53e-05	0.00205	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Fluoropyrimidine Activity—TP53—psoriasis	1.52e-05	0.00205	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	1.52e-05	0.00204	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—PPARA activates gene expression—PPARG—psoriasis	1.46e-05	0.00197	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	1.43e-05	0.00193	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Biological oxidations—CYP2S1—psoriasis	1.42e-05	0.00191	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	1.4e-05	0.00189	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—NDUFA5—psoriasis	1.38e-05	0.00186	CbGpPWpGaD
Mycophenolate mofetil—ALB—Selenium Micronutrient Network—CAT—psoriasis	1.35e-05	0.00182	CbGpPWpGaD
Mycophenolate mofetil—ALB—Folate Metabolism—CRP—psoriasis	1.35e-05	0.00182	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	1.35e-05	0.00181	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—HIF-1-alpha transcription factor network—JUN—psoriasis	1.33e-05	0.00178	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—CARM1—psoriasis	1.3e-05	0.00175	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.29e-05	0.00173	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Transmembrane transport of small molecules—CP—psoriasis	1.28e-05	0.00173	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—NDUFA5—psoriasis	1.25e-05	0.00167	CbGpPWpGaD
Mycophenolate mofetil—ALB—Folate Metabolism—ICAM1—psoriasis	1.24e-05	0.00167	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Tryptophan metabolism—CAT—psoriasis	1.23e-05	0.00165	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Transmembrane transport of small molecules—CARM1—psoriasis	1.22e-05	0.00165	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—IL10—psoriasis	1.22e-05	0.00164	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—IL4—psoriasis	1.19e-05	0.0016	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—CYP2S1—psoriasis	1.17e-05	0.00158	CbGpPWpGaD
Mycophenolate mofetil—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	1.16e-05	0.00156	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—HLA-B—psoriasis	1.16e-05	0.00156	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	1.16e-05	0.00156	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—HIF-1-alpha transcription factor network—VEGFA—psoriasis	1.16e-05	0.00156	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—CAT—psoriasis	1.15e-05	0.00155	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	1.08e-05	0.00145	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—HLA-A—psoriasis	1.08e-05	0.00145	CbGpPWpGaD
Mycophenolate mofetil—ALB—Selenium Micronutrient Network—CRP—psoriasis	1.07e-05	0.00144	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—CYP2S1—psoriasis	1.06e-05	0.00142	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.06e-05	0.00142	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—CAT—psoriasis	1.03e-05	0.00138	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—NDUFA5—psoriasis	1.01e-05	0.00136	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—NDUFA5—psoriasis	1.01e-05	0.00136	CbGpPWpGaD
Mycophenolate mofetil—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	9.88e-06	0.00133	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	9.87e-06	0.00133	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	9.83e-06	0.00132	CbGpPWpGaD
Mycophenolate mofetil—ALB—SLC-mediated transmembrane transport—CP—psoriasis	9.7e-06	0.0013	CbGpPWpGaD
Mycophenolate mofetil—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	9.68e-06	0.0013	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—CARM1—psoriasis	9.48e-06	0.00127	CbGpPWpGaD
Mycophenolate mofetil—ALB—Folate Metabolism—IFNG—psoriasis	9.46e-06	0.00127	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	9.44e-06	0.00127	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—CAT—psoriasis	9.4e-06	0.00126	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—NDUFA5—psoriasis	9.28e-06	0.00125	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	9.18e-06	0.00123	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—APOE—psoriasis	8.96e-06	0.0012	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	8.76e-06	0.00118	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.65e-06	0.00116	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—CP—psoriasis	8.63e-06	0.00116	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CYP2S1—psoriasis	8.61e-06	0.00116	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CYP2S1—psoriasis	8.61e-06	0.00116	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—NDUFA5—psoriasis	8.59e-06	0.00115	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—CARM1—psoriasis	8.23e-06	0.00111	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—CAT—psoriasis	8e-06	0.00107	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—APOE—psoriasis	7.99e-06	0.00107	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	7.99e-06	0.00107	CbGpPWpGaD
Mycophenolate mofetil—Malnutrition—Prednisone—psoriasis	7.92e-06	0.000124	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Hydrocortisone—psoriasis	7.92e-06	0.000124	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Triamcinolone—psoriasis	7.91e-06	0.000124	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Methotrexate—psoriasis	7.91e-06	0.000124	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Metabolism—CYP2S1—psoriasis	7.89e-06	0.00106	CbGpPWpGaD
Mycophenolate mofetil—Convulsion—Dexamethasone—psoriasis	7.88e-06	0.000124	CcSEcCtD
Mycophenolate mofetil—Convulsion—Betamethasone—psoriasis	7.88e-06	0.000124	CcSEcCtD
Mycophenolate mofetil—ALB—Folate Metabolism—NFKB1—psoriasis	7.87e-06	0.00106	CbGpPWpGaD
Mycophenolate mofetil—Insomnia—Hydrocortisone—psoriasis	7.86e-06	0.000123	CcSEcCtD
Mycophenolate mofetil—Hypertension—Betamethasone—psoriasis	7.85e-06	0.000123	CcSEcCtD
Mycophenolate mofetil—Hypertension—Dexamethasone—psoriasis	7.85e-06	0.000123	CcSEcCtD
Mycophenolate mofetil—IMPDH2—Metabolism—PPARG—psoriasis	7.81e-06	0.00105	CbGpPWpGaD
Mycophenolate mofetil—Paraesthesia—Hydrocortisone—psoriasis	7.8e-06	0.000123	CcSEcCtD
Mycophenolate mofetil—Urticaria—Cyclosporine—psoriasis	7.77e-06	0.000122	CcSEcCtD
Mycophenolate mofetil—Myalgia—Betamethasone—psoriasis	7.74e-06	0.000122	CcSEcCtD
Mycophenolate mofetil—Myalgia—Dexamethasone—psoriasis	7.74e-06	0.000122	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Cyclosporine—psoriasis	7.73e-06	0.000121	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Cyclosporine—psoriasis	7.73e-06	0.000121	CcSEcCtD
Mycophenolate mofetil—Anxiety—Dexamethasone—psoriasis	7.72e-06	0.000121	CcSEcCtD
Mycophenolate mofetil—Anxiety—Betamethasone—psoriasis	7.72e-06	0.000121	CcSEcCtD
Mycophenolate mofetil—Vomiting—Mycophenolic acid—psoriasis	7.68e-06	0.000121	CcSEcCtD
Mycophenolate mofetil—Discomfort—Betamethasone—psoriasis	7.65e-06	0.00012	CcSEcCtD
Mycophenolate mofetil—Discomfort—Dexamethasone—psoriasis	7.65e-06	0.00012	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Hydrocortisone—psoriasis	7.65e-06	0.00012	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Methotrexate—psoriasis	7.64e-06	0.00012	CcSEcCtD
Mycophenolate mofetil—Rash—Mycophenolic acid—psoriasis	7.62e-06	0.00012	CcSEcCtD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	7.62e-06	0.00102	CbGpPWpGaD
Mycophenolate mofetil—Dermatitis—Mycophenolic acid—psoriasis	7.61e-06	0.00012	CcSEcCtD
Mycophenolate mofetil—Pain—Prednisolone—psoriasis	7.61e-06	0.00012	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Methotrexate—psoriasis	7.61e-06	0.000119	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Methotrexate—psoriasis	7.61e-06	0.000119	CcSEcCtD
Mycophenolate mofetil—Headache—Mycophenolic acid—psoriasis	7.57e-06	0.000119	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Hydrocortisone—psoriasis	7.55e-06	0.000119	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Methotrexate—psoriasis	7.55e-06	0.000119	CcSEcCtD
Mycophenolate mofetil—ALB—Vitamin B12 Metabolism—TNF—psoriasis	7.53e-06	0.00101	CbGpPWpGaD
Mycophenolate mofetil—ALB—Selenium Micronutrient Network—IFNG—psoriasis	7.52e-06	0.00101	CbGpPWpGaD
Mycophenolate mofetil—Urinary tract disorder—Methotrexate—psoriasis	7.51e-06	0.000118	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Hydrocortisone—psoriasis	7.5e-06	0.000118	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Methotrexate—psoriasis	7.46e-06	0.000117	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Triamcinolone—psoriasis	7.45e-06	0.000117	CcSEcCtD
Mycophenolate mofetil—Pain—Hydrocortisone—psoriasis	7.43e-06	0.000117	CcSEcCtD
Mycophenolate mofetil—Oedema—Dexamethasone—psoriasis	7.42e-06	0.000117	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Betamethasone—psoriasis	7.42e-06	0.000117	CcSEcCtD
Mycophenolate mofetil—Oedema—Betamethasone—psoriasis	7.42e-06	0.000117	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Dexamethasone—psoriasis	7.42e-06	0.000117	CcSEcCtD
Mycophenolate mofetil—Insomnia—Triamcinolone—psoriasis	7.4e-06	0.000116	CcSEcCtD
Mycophenolate mofetil—Infection—Betamethasone—psoriasis	7.38e-06	0.000116	CcSEcCtD
Mycophenolate mofetil—Infection—Dexamethasone—psoriasis	7.38e-06	0.000116	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Prednisone—psoriasis	7.35e-06	0.000115	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Triamcinolone—psoriasis	7.35e-06	0.000115	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Prednisolone—psoriasis	7.33e-06	0.000115	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Methotrexate—psoriasis	7.33e-06	0.000115	CcSEcCtD
Mycophenolate mofetil—Anaemia—Prednisone—psoriasis	7.32e-06	0.000115	CcSEcCtD
Mycophenolate mofetil—ABCG2—Metabolism—CYP2S1—psoriasis	7.31e-06	0.000982	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—APOE—psoriasis	7.31e-06	0.000982	CbGpPWpGaD
Mycophenolate mofetil—Shock—Dexamethasone—psoriasis	7.3e-06	0.000115	CcSEcCtD
Mycophenolate mofetil—Shock—Betamethasone—psoriasis	7.3e-06	0.000115	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Triamcinolone—psoriasis	7.29e-06	0.000115	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Betamethasone—psoriasis	7.28e-06	0.000114	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Dexamethasone—psoriasis	7.28e-06	0.000114	CcSEcCtD
Mycophenolate mofetil—Agitation—Prednisone—psoriasis	7.28e-06	0.000114	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Dexamethasone—psoriasis	7.27e-06	0.000114	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Betamethasone—psoriasis	7.27e-06	0.000114	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Betamethasone—psoriasis	7.25e-06	0.000114	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Dexamethasone—psoriasis	7.25e-06	0.000114	CcSEcCtD
Mycophenolate mofetil—Angioedema—Prednisone—psoriasis	7.24e-06	0.000114	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Cyclosporine—psoriasis	7.2e-06	0.000113	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Triamcinolone—psoriasis	7.2e-06	0.000113	CcSEcCtD
Mycophenolate mofetil—ABCB1—Allograft Rejection—IFNG—psoriasis	7.18e-06	0.000965	CbGpPWpGaD
Mycophenolate mofetil—Nausea—Mycophenolic acid—psoriasis	7.18e-06	0.000113	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Dexamethasone—psoriasis	7.18e-06	0.000113	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Betamethasone—psoriasis	7.18e-06	0.000113	CcSEcCtD
Mycophenolate mofetil—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	7.17e-06	0.000963	CbGpPWpGaD
Mycophenolate mofetil—Feeling abnormal—Hydrocortisone—psoriasis	7.16e-06	0.000112	CcSEcCtD
Mycophenolate mofetil—Malaise—Prednisone—psoriasis	7.14e-06	0.000112	CcSEcCtD
Mycophenolate mofetil—Vertigo—Prednisone—psoriasis	7.12e-06	0.000112	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Methotrexate—psoriasis	7.11e-06	0.000112	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Hydrocortisone—psoriasis	7.11e-06	0.000112	CcSEcCtD
Mycophenolate mofetil—Syncope—Prednisone—psoriasis	7.1e-06	0.000112	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Methotrexate—psoriasis	7.09e-06	0.000111	CcSEcCtD
Mycophenolate mofetil—Anorexia—Betamethasone—psoriasis	7.08e-06	0.000111	CcSEcCtD
Mycophenolate mofetil—Anorexia—Dexamethasone—psoriasis	7.08e-06	0.000111	CcSEcCtD
Mycophenolate mofetil—Urticaria—Prednisolone—psoriasis	7.07e-06	0.000111	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Methotrexate—psoriasis	7.06e-06	0.000111	CcSEcCtD
Mycophenolate mofetil—Asthenia—Cyclosporine—psoriasis	7.02e-06	0.00011	CcSEcCtD
Mycophenolate mofetil—Pain—Triamcinolone—psoriasis	7e-06	0.00011	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Prednisone—psoriasis	6.96e-06	0.000109	CcSEcCtD
Mycophenolate mofetil—UGT1A7—Metabolism—PPARG—psoriasis	6.96e-06	0.000935	CbGpPWpGaD
Mycophenolate mofetil—Hypotension—Betamethasone—psoriasis	6.94e-06	0.000109	CcSEcCtD
Mycophenolate mofetil—Hypotension—Dexamethasone—psoriasis	6.94e-06	0.000109	CcSEcCtD
Mycophenolate mofetil—Pruritus—Cyclosporine—psoriasis	6.92e-06	0.000109	CcSEcCtD
Mycophenolate mofetil—Urticaria—Hydrocortisone—psoriasis	6.9e-06	0.000108	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Methotrexate—psoriasis	6.9e-06	0.000108	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Hydrocortisone—psoriasis	6.87e-06	0.000108	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Hydrocortisone—psoriasis	6.87e-06	0.000108	CcSEcCtD
Mycophenolate mofetil—Convulsion—Prednisone—psoriasis	6.86e-06	0.000108	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Methotrexate—psoriasis	6.85e-06	0.000108	CcSEcCtD
Mycophenolate mofetil—Hypertension—Prednisone—psoriasis	6.84e-06	0.000107	CcSEcCtD
Mycophenolate mofetil—Chills—Methotrexate—psoriasis	6.82e-06	0.000107	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Betamethasone—psoriasis	6.76e-06	0.000106	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Dexamethasone—psoriasis	6.76e-06	0.000106	CcSEcCtD
Mycophenolate mofetil—Myalgia—Prednisone—psoriasis	6.74e-06	0.000106	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Prednisone—psoriasis	6.74e-06	0.000106	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Triamcinolone—psoriasis	6.74e-06	0.000106	CcSEcCtD
Mycophenolate mofetil—Anxiety—Prednisone—psoriasis	6.72e-06	0.000106	CcSEcCtD
Mycophenolate mofetil—Alopecia—Methotrexate—psoriasis	6.72e-06	0.000106	CcSEcCtD
Mycophenolate mofetil—Insomnia—Dexamethasone—psoriasis	6.71e-06	0.000105	CcSEcCtD
Mycophenolate mofetil—Insomnia—Betamethasone—psoriasis	6.71e-06	0.000105	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	6.7e-06	0.000105	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Cyclosporine—psoriasis	6.69e-06	0.000105	CcSEcCtD
Mycophenolate mofetil—ABCB1—Allograft Rejection—CXCL8—psoriasis	6.68e-06	0.000897	CbGpPWpGaD
Mycophenolate mofetil—Paraesthesia—Betamethasone—psoriasis	6.67e-06	0.000105	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Dexamethasone—psoriasis	6.67e-06	0.000105	CcSEcCtD
Mycophenolate mofetil—Discomfort—Prednisone—psoriasis	6.66e-06	0.000105	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Methotrexate—psoriasis	6.66e-06	0.000105	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Methotrexate—psoriasis	6.62e-06	0.000104	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Prednisolone—psoriasis	6.56e-06	0.000103	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Dexamethasone—psoriasis	6.54e-06	0.000103	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Betamethasone—psoriasis	6.54e-06	0.000103	CcSEcCtD
Mycophenolate mofetil—Urticaria—Triamcinolone—psoriasis	6.5e-06	0.000102	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Methotrexate—psoriasis	6.48e-06	0.000102	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Triamcinolone—psoriasis	6.47e-06	0.000102	CcSEcCtD
Mycophenolate mofetil—Dizziness—Cyclosporine—psoriasis	6.47e-06	0.000102	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Prednisone—psoriasis	6.47e-06	0.000102	CcSEcCtD
Mycophenolate mofetil—Oedema—Prednisone—psoriasis	6.47e-06	0.000102	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Dexamethasone—psoriasis	6.45e-06	0.000101	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Betamethasone—psoriasis	6.45e-06	0.000101	CcSEcCtD
Mycophenolate mofetil—Infection—Prednisone—psoriasis	6.42e-06	0.000101	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Dexamethasone—psoriasis	6.41e-06	0.000101	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Betamethasone—psoriasis	6.41e-06	0.000101	CcSEcCtD
Mycophenolate mofetil—Back pain—Methotrexate—psoriasis	6.4e-06	0.000101	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Hydrocortisone—psoriasis	6.4e-06	0.000101	CcSEcCtD
Mycophenolate mofetil—IMPDH1—Metabolism—PPARG—psoriasis	6.36e-06	0.000855	CbGpPWpGaD
Mycophenolate mofetil—Shock—Prednisone—psoriasis	6.36e-06	9.99e-05	CcSEcCtD
Mycophenolate mofetil—Pain—Dexamethasone—psoriasis	6.35e-06	9.97e-05	CcSEcCtD
Mycophenolate mofetil—Pain—Betamethasone—psoriasis	6.35e-06	9.97e-05	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Prednisone—psoriasis	6.34e-06	9.96e-05	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Prednisone—psoriasis	6.31e-06	9.91e-05	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Prednisone—psoriasis	6.28e-06	9.86e-05	CcSEcCtD
Mycophenolate mofetil—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	6.26e-06	0.000841	CbGpPWpGaD
Mycophenolate mofetil—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	6.26e-06	0.000841	CbGpPWpGaD
Mycophenolate mofetil—Hyperhidrosis—Prednisone—psoriasis	6.25e-06	9.82e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Hydrocortisone—psoriasis	6.23e-06	9.79e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Cyclosporine—psoriasis	6.22e-06	9.76e-05	CcSEcCtD
Mycophenolate mofetil—UGT1A8—Metabolism—APOE—psoriasis	6.21e-06	0.000835	CbGpPWpGaD
Mycophenolate mofetil—Rash—Cyclosporine—psoriasis	6.16e-06	9.68e-05	CcSEcCtD
Mycophenolate mofetil—Anorexia—Prednisone—psoriasis	6.16e-06	9.68e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Cyclosporine—psoriasis	6.16e-06	9.67e-05	CcSEcCtD
Mycophenolate mofetil—CYP3A5—Metabolism—NDUFA5—psoriasis	6.16e-06	0.000827	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.16e-06	0.000827	CbGpPWpGaD
Mycophenolate mofetil—Pruritus—Hydrocortisone—psoriasis	6.15e-06	9.66e-05	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Methotrexate—psoriasis	6.14e-06	9.65e-05	CcSEcCtD
Mycophenolate mofetil—ALB—Platelet degranulation—VEGFA—psoriasis	6.13e-06	0.000823	CbGpPWpGaD
Mycophenolate mofetil—Headache—Cyclosporine—psoriasis	6.13e-06	9.62e-05	CcSEcCtD
Mycophenolate mofetil—ALB—Folate Metabolism—TNF—psoriasis	6.12e-06	0.000823	CbGpPWpGaD
Mycophenolate mofetil—Anaemia—Methotrexate—psoriasis	6.12e-06	9.61e-05	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Betamethasone—psoriasis	6.12e-06	9.61e-05	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Dexamethasone—psoriasis	6.12e-06	9.61e-05	CcSEcCtD
Mycophenolate mofetil—ALB—Vitamin B12 Metabolism—IL6—psoriasis	6.07e-06	0.000816	CbGpPWpGaD
Mycophenolate mofetil—Gastrointestinal pain—Betamethasone—psoriasis	6.07e-06	9.53e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Dexamethasone—psoriasis	6.07e-06	9.53e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Triamcinolone—psoriasis	6.03e-06	9.47e-05	CcSEcCtD
Mycophenolate mofetil—Malaise—Methotrexate—psoriasis	5.97e-06	9.38e-05	CcSEcCtD
Mycophenolate mofetil—Vertigo—Methotrexate—psoriasis	5.95e-06	9.34e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Hydrocortisone—psoriasis	5.95e-06	9.34e-05	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Methotrexate—psoriasis	5.93e-06	9.31e-05	CcSEcCtD
Mycophenolate mofetil—Urticaria—Betamethasone—psoriasis	5.9e-06	9.26e-05	CcSEcCtD
Mycophenolate mofetil—Urticaria—Dexamethasone—psoriasis	5.9e-06	9.26e-05	CcSEcCtD
Mycophenolate mofetil—ALB—Hemostasis—ITGAL—psoriasis	5.89e-06	0.000792	CbGpPWpGaD
Mycophenolate mofetil—Musculoskeletal discomfort—Prednisone—psoriasis	5.89e-06	9.25e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Prednisolone—psoriasis	5.88e-06	9.24e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Triamcinolone—psoriasis	5.87e-06	9.22e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Betamethasone—psoriasis	5.87e-06	9.22e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Betamethasone—psoriasis	5.87e-06	9.22e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Dexamethasone—psoriasis	5.87e-06	9.22e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Dexamethasone—psoriasis	5.87e-06	9.22e-05	CcSEcCtD
Mycophenolate mofetil—Insomnia—Prednisone—psoriasis	5.85e-06	9.18e-05	CcSEcCtD
Mycophenolate mofetil—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	5.84e-06	0.000784	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—CAT—psoriasis	5.83e-06	0.000784	CbGpPWpGaD
Mycophenolate mofetil—Nausea—Cyclosporine—psoriasis	5.81e-06	9.12e-05	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Prednisone—psoriasis	5.81e-06	9.12e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Triamcinolone—psoriasis	5.79e-06	9.09e-05	CcSEcCtD
Mycophenolate mofetil—Cough—Methotrexate—psoriasis	5.78e-06	9.07e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Hydrocortisone—psoriasis	5.75e-06	9.03e-05	CcSEcCtD
Mycophenolate mofetil—Convulsion—Methotrexate—psoriasis	5.74e-06	9.01e-05	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—Metabolism—CARM1—psoriasis	5.74e-06	0.000771	CbGpPWpGaD
Mycophenolate mofetil—Dyspepsia—Prednisone—psoriasis	5.69e-06	8.94e-05	CcSEcCtD
Mycophenolate mofetil—Chest pain—Methotrexate—psoriasis	5.64e-06	8.85e-05	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Methotrexate—psoriasis	5.64e-06	8.85e-05	CcSEcCtD
Mycophenolate mofetil—Myalgia—Methotrexate—psoriasis	5.64e-06	8.85e-05	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Prednisone—psoriasis	5.62e-06	8.83e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Prednisolone—psoriasis	5.61e-06	8.81e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Prednisolone—psoriasis	5.6e-06	8.8e-05	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	5.6e-06	8.79e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Prednisolone—psoriasis	5.57e-06	8.75e-05	CcSEcCtD
Mycophenolate mofetil—Discomfort—Methotrexate—psoriasis	5.57e-06	8.75e-05	CcSEcCtD
Mycophenolate mofetil—Constipation—Prednisone—psoriasis	5.53e-06	8.68e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Hydrocortisone—psoriasis	5.52e-06	8.68e-05	CcSEcCtD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	5.5e-06	0.000739	CbGpPWpGaD
Mycophenolate mofetil—Rash—Hydrocortisone—psoriasis	5.48e-06	8.61e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Hydrocortisone—psoriasis	5.47e-06	8.6e-05	CcSEcCtD
Mycophenolate mofetil—Confusional state—Methotrexate—psoriasis	5.45e-06	8.56e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Hydrocortisone—psoriasis	5.44e-06	8.55e-05	CcSEcCtD
Mycophenolate mofetil—ABCB1—Allograft Rejection—VEGFA—psoriasis	5.42e-06	0.000729	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—PPARG—psoriasis	5.41e-06	0.000727	CbGpPWpGaD
Mycophenolate mofetil—Dizziness—Triamcinolone—psoriasis	5.41e-06	8.5e-05	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Methotrexate—psoriasis	5.4e-06	8.49e-05	CcSEcCtD
Mycophenolate mofetil—ALB—Folate Metabolism—TP53—psoriasis	5.4e-06	0.000726	CbGpPWpGaD
Mycophenolate mofetil—Infection—Methotrexate—psoriasis	5.37e-06	8.43e-05	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.36e-06	0.000721	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—NDUFA5—psoriasis	5.33e-06	0.000717	CbGpPWpGaD
Mycophenolate mofetil—Feeling abnormal—Prednisone—psoriasis	5.33e-06	8.37e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Betamethasone—psoriasis	5.33e-06	8.37e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Dexamethasone—psoriasis	5.33e-06	8.37e-05	CcSEcCtD
Mycophenolate mofetil—ALB—Metabolism—NDUFA5—psoriasis	5.3e-06	0.000713	CbGpPWpGaD
Mycophenolate mofetil—Nervous system disorder—Methotrexate—psoriasis	5.3e-06	8.32e-05	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Methotrexate—psoriasis	5.29e-06	8.31e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Prednisone—psoriasis	5.29e-06	8.3e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Prednisolone—psoriasis	5.28e-06	8.3e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Dexamethasone—psoriasis	5.25e-06	8.25e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Betamethasone—psoriasis	5.25e-06	8.25e-05	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Methotrexate—psoriasis	5.25e-06	8.24e-05	CcSEcCtD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP2S1—psoriasis	5.24e-06	0.000704	CbGpPWpGaD
Mycophenolate mofetil—Hyperhidrosis—Methotrexate—psoriasis	5.22e-06	8.2e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Triamcinolone—psoriasis	5.2e-06	8.17e-05	CcSEcCtD
Mycophenolate mofetil—UGT2B7—Metabolism—CARM1—psoriasis	5.18e-06	0.000696	CbGpPWpGaD
Mycophenolate mofetil—Nausea—Hydrocortisone—psoriasis	5.16e-06	8.11e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Triamcinolone—psoriasis	5.16e-06	8.1e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Triamcinolone—psoriasis	5.15e-06	8.1e-05	CcSEcCtD
Mycophenolate mofetil—Anorexia—Methotrexate—psoriasis	5.15e-06	8.09e-05	CcSEcCtD
Mycophenolate mofetil—Urticaria—Prednisone—psoriasis	5.14e-06	8.07e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Triamcinolone—psoriasis	5.13e-06	8.05e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Prednisone—psoriasis	5.11e-06	8.03e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Prednisone—psoriasis	5.11e-06	8.03e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Betamethasone—psoriasis	5.08e-06	7.98e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Dexamethasone—psoriasis	5.08e-06	7.98e-05	CcSEcCtD
Mycophenolate mofetil—Hypotension—Methotrexate—psoriasis	5.05e-06	7.93e-05	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.97e-06	0.000668	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.94e-06	0.000664	CbGpPWpGaD
Mycophenolate mofetil—ALB—Folate Metabolism—IL6—psoriasis	4.94e-06	0.000664	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—CP—psoriasis	4.93e-06	0.000662	CbGpPWpGaD
Mycophenolate mofetil—Musculoskeletal discomfort—Methotrexate—psoriasis	4.92e-06	7.73e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Dexamethasone—psoriasis	4.91e-06	7.71e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Betamethasone—psoriasis	4.91e-06	7.71e-05	CcSEcCtD
Mycophenolate mofetil—Insomnia—Methotrexate—psoriasis	4.89e-06	7.68e-05	CcSEcCtD
Mycophenolate mofetil—ALB—Selenium Micronutrient Network—TNF—psoriasis	4.87e-06	0.000654	CbGpPWpGaD
Mycophenolate mofetil—Nausea—Triamcinolone—psoriasis	4.86e-06	7.63e-05	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Methotrexate—psoriasis	4.85e-06	7.62e-05	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Methotrexate—psoriasis	4.82e-06	7.57e-05	CcSEcCtD
Mycophenolate mofetil—Somnolence—Methotrexate—psoriasis	4.8e-06	7.54e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Prednisone—psoriasis	4.76e-06	7.48e-05	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Methotrexate—psoriasis	4.76e-06	7.47e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Betamethasone—psoriasis	4.72e-06	7.41e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Dexamethasone—psoriasis	4.72e-06	7.41e-05	CcSEcCtD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	4.7e-06	0.000632	CbGpPWpGaD
Mycophenolate mofetil—Decreased appetite—Methotrexate—psoriasis	4.7e-06	7.38e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Betamethasone—psoriasis	4.68e-06	7.35e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Dexamethasone—psoriasis	4.68e-06	7.35e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Betamethasone—psoriasis	4.68e-06	7.35e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Dexamethasone—psoriasis	4.68e-06	7.35e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Methotrexate—psoriasis	4.66e-06	7.33e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Dexamethasone—psoriasis	4.65e-06	7.3e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Betamethasone—psoriasis	4.65e-06	7.3e-05	CcSEcCtD
Mycophenolate mofetil—ABCB1—Allograft Rejection—TNF—psoriasis	4.65e-06	0.000625	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NDUFA5—psoriasis	4.65e-06	0.000624	CbGpPWpGaD
Mycophenolate mofetil—Asthenia—Prednisone—psoriasis	4.64e-06	7.29e-05	CcSEcCtD
Mycophenolate mofetil—Pain—Methotrexate—psoriasis	4.62e-06	7.26e-05	CcSEcCtD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	4.62e-06	0.000621	CbGpPWpGaD
Mycophenolate mofetil—Pruritus—Prednisone—psoriasis	4.57e-06	7.18e-05	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP2S1—psoriasis	4.53e-06	0.000609	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—APOE—psoriasis	4.53e-06	0.000609	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.51e-06	0.000606	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP2S1—psoriasis	4.51e-06	0.000606	CbGpPWpGaD
Mycophenolate mofetil—Feeling abnormal—Methotrexate—psoriasis	4.45e-06	6.99e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Prednisone—psoriasis	4.42e-06	6.95e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Methotrexate—psoriasis	4.42e-06	6.94e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Betamethasone—psoriasis	4.41e-06	6.93e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Dexamethasone—psoriasis	4.41e-06	6.93e-05	CcSEcCtD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	4.32e-06	0.00058	CbGpPWpGaD
Mycophenolate mofetil—Urticaria—Methotrexate—psoriasis	4.29e-06	6.74e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Prednisone—psoriasis	4.28e-06	6.72e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Methotrexate—psoriasis	4.27e-06	6.71e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Methotrexate—psoriasis	4.27e-06	6.71e-05	CcSEcCtD
Mycophenolate mofetil—UGT1A9—Metabolism—CARM1—psoriasis	4.21e-06	0.000565	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CARM1—psoriasis	4.21e-06	0.000565	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.14e-06	0.000556	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	4.12e-06	0.000554	CbGpPWpGaD
Mycophenolate mofetil—Vomiting—Prednisone—psoriasis	4.11e-06	6.46e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Prednisone—psoriasis	4.08e-06	6.4e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Prednisone—psoriasis	4.07e-06	6.4e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Prednisone—psoriasis	4.05e-06	6.36e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Methotrexate—psoriasis	3.98e-06	6.25e-05	CcSEcCtD
Mycophenolate mofetil—ABCB1—Metabolism—CYP2S1—psoriasis	3.95e-06	0.000531	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PPARG—psoriasis	3.95e-06	0.000531	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.93e-06	0.000528	CbGpPWpGaD
Mycophenolate mofetil—ALB—Selenium Micronutrient Network—IL6—psoriasis	3.93e-06	0.000528	CbGpPWpGaD
Mycophenolate mofetil—Asthenia—Methotrexate—psoriasis	3.88e-06	6.09e-05	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Metabolism—CARM1—psoriasis	3.85e-06	0.000518	CbGpPWpGaD
Mycophenolate mofetil—Nausea—Prednisone—psoriasis	3.84e-06	6.03e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Methotrexate—psoriasis	3.82e-06	6e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Methotrexate—psoriasis	3.7e-06	5.81e-05	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.6e-06	0.000484	CbGpPWpGaD
Mycophenolate mofetil—Dizziness—Methotrexate—psoriasis	3.57e-06	5.61e-05	CcSEcCtD
Mycophenolate mofetil—ABCG2—Metabolism—CARM1—psoriasis	3.57e-06	0.00048	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—CAT—psoriasis	3.53e-06	0.000474	CbGpPWpGaD
Mycophenolate mofetil—Vomiting—Methotrexate—psoriasis	3.44e-06	5.4e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Methotrexate—psoriasis	3.41e-06	5.35e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Methotrexate—psoriasis	3.4e-06	5.35e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Methotrexate—psoriasis	3.38e-06	5.32e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Methotrexate—psoriasis	3.21e-06	5.04e-05	CcSEcCtD
Mycophenolate mofetil—UGT2B7—Metabolism—CAT—psoriasis	3.18e-06	0.000428	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	3.06e-06	0.000412	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.95e-06	0.000396	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NDUFA5—psoriasis	2.86e-06	0.000385	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—APOE—psoriasis	2.74e-06	0.000368	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	2.72e-06	0.000365	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.68e-06	0.00036	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CAT—psoriasis	2.59e-06	0.000348	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CAT—psoriasis	2.59e-06	0.000348	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CARM1—psoriasis	2.56e-06	0.000344	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—APOE—psoriasis	2.47e-06	0.000332	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP2S1—psoriasis	2.43e-06	0.000327	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—NOS2—psoriasis	2.42e-06	0.000325	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PPARG—psoriasis	2.39e-06	0.000321	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.38e-06	0.000319	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CAT—psoriasis	2.37e-06	0.000319	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.36e-06	0.000318	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	2.29e-06	0.000308	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CARM1—psoriasis	2.21e-06	0.000298	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CARM1—psoriasis	2.2e-06	0.000296	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CAT—psoriasis	2.19e-06	0.000295	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PPARG—psoriasis	2.15e-06	0.00029	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.07e-06	0.000278	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.06e-06	0.000277	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.02e-06	0.000272	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—APOE—psoriasis	2.01e-06	0.00027	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—APOE—psoriasis	2.01e-06	0.00027	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CARM1—psoriasis	1.93e-06	0.000259	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—APOE—psoriasis	1.84e-06	0.000248	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PPARG—psoriasis	1.75e-06	0.000235	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PPARG—psoriasis	1.75e-06	0.000235	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—APOE—psoriasis	1.71e-06	0.000229	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PPARG—psoriasis	1.6e-06	0.000216	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CAT—psoriasis	1.57e-06	0.000211	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PPARG—psoriasis	1.49e-06	0.0002	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—VEGFA—psoriasis	1.4e-06	0.000188	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CAT—psoriasis	1.36e-06	0.000183	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CAT—psoriasis	1.35e-06	0.000182	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—APOE—psoriasis	1.22e-06	0.000164	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CARM1—psoriasis	1.19e-06	0.00016	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CAT—psoriasis	1.19e-06	0.000159	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PPARG—psoriasis	1.06e-06	0.000143	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TP53—psoriasis	1.06e-06	0.000142	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—APOE—psoriasis	1.06e-06	0.000142	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—APOE—psoriasis	1.05e-06	0.000141	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—APOE—psoriasis	9.22e-07	0.000124	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PPARG—psoriasis	9.22e-07	0.000124	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PPARG—psoriasis	9.17e-07	0.000123	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PPARG—psoriasis	8.03e-07	0.000108	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CAT—psoriasis	7.31e-07	9.82e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—APOE—psoriasis	5.68e-07	7.63e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PPARG—psoriasis	4.95e-07	6.65e-05	CbGpPWpGaD
